IPO registrations (S-1, F-1) · Registrants
DENDREON CORP
- SEC CIK
- 1107332 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2000-03-08, last 2000-10-25; 2 initial registrations, 4 amendments
- Outcome
- No final prospectus, effectiveness notice or withdrawal within two years of the registration
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 601 UNION STREET, SUITE 4900, Seattle, WA 98101
- EIN
- 22-3203193
- EDGAR entity type
- operating
- Insiders and CEO pay
- DENDREON CORP on the corporate pages
Offering terms
- Shares offered
- 2,500,000
- Listing
- Nasdaq under the symbol DNDN
- Lead underwriters
- Prudential Securities
- Syndicate
- Cowen; Pacific Growth Equities, Inc
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: DENDREON CORPORATION Fuzzy (name and state)
- Form 5500 plan sponsor: DENDREON PHARMACEUTICALS LLC EXACT (EIN (EXACT))
- Federal award recipient: DENDREON CORPORATION Fuzzy (name and state)
- Lobbying client: DENDREON CORP. Fuzzy (name and state)
- Lobbying client: DENDREON CORPORATION Fuzzy (name and state)
- Lobbying client: DENDREON CORPORATION Fuzzy (name and state)
- SEC filer: DENDREON CORP EXACT (CIK (EXACT))
- Person page: David C Stump MD Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: Douglas G Watson Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: Pedro P Granadillo Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 6
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2000-03-08 | S-1 | S-1 (registration) | DENDREON CORP | 0001032210-00-000420 ↗ |
| 2000-05-22 | S-1/A | S-1/A (amendment) | DENDREON CORP | 0001032210-00-001103 ↗ |
| 2000-06-15 | S-1/A | S-1/A (amendment) | DENDREON CORP | 0001032210-00-001212 ↗ |
| 2000-06-16 | S-1/A | S-1/A (amendment) | DENDREON CORP | 0000898430-00-001820 ↗ |
| 2000-10-11 | S-1 | S-1 (registration) | DENDREON CORP | 0001032210-00-002021 ↗ |
| 2000-10-25 | S-1/A | S-1/A (amendment) | DENDREON CORP | 0001032210-00-002079 ↗ |
Prospectus pages read 1
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2000-10-25 | S-1/A | registration statement | 2,500,000 | - | Nasdaq DNDN | 3 | primary document; shares headline, cover names 3 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| GOLD MITCHELL | Director; Director,Officer; Officer | President & CEO; President & Chief Executive Of | 51 | 2006–2013 | |
| HAMM RICHARD F JR | Officer | EVP, General Counsel Secretary; SVP, Gen. Counsel Secretary; SVP General Counsel Secretary; SVP, General Counsel Secretary | 39 | 2006–2011 | |
| HERSHBERG ROBERT | Officer | Sr. VP & Chief Medical Officer | 2 | 2006 | |
| URDAL DAVID | Director; Director,Officer; Officer | SVP, Chief Science Officer; SVP, Chief Scientific Officer | 39 | 2006–2014 | |
| WATSON DOUGLAS G | Director | Board of Director | 13 | 2006–2014 | person page Fuzzy |
| DZIURZYNSKI BOGDAN | Director | Board of Director | 15 | 2006–2014 | |
| KUNATH RUTH | Director | 7 | 2006–2007 | ||
| BAYH SUSAN B | Director | Board of Director | 12 | 2006–2014 | |
| BREWER RICHARD B | Director | Board of Director | 10 | 2006–2012 | |
| CANET GERARDO | Director | Board of Director | 15 | 2006–2013 | |
| INGLE M BLAKE | Director | 4 | 2006–2009 | ||
| SCHIFFMAN GREGORY T | Officer | CFO, EVP of Finance & Treasure; CFO, SVP of Finance & Treasure; EVP; EVP, CFO and Treasurer; Sr. VP, CFO & Treasurer | 50 | 2006–2013 | |
| Frohlich Mark W | Officer; OfficerOther | Chief Medical Officer; EVP, R&D and CMO; See General Remarks; see remarks; See Remarks; SVP,CA & Chief MO; SVP,CA & MO; SVP, Clinical Affairs; SVP, Clinical Affairs&Med Off; Vice President | 54 | 2007–2014 | |
| Cox Greg | Officer; Other | EVP, CFO & Treasurer; Principal Accounting Officer; VP, Finance; VP, Interim CFO and Treasurer; VP, Interim CFO & Treasurer; VP of Accounting | 58 | 2009–2015 | |
| CLARK IAN T | Director; Director,Officer | Board of Director | 6 | 2009–2010 | |
| GRANADILLO PEDRO P | Director; Director,Officer | Board of Director | 9 | 2009–2014 | person page Fuzzy |
| Bishop Hans Edgar | Officer | Chief Operating Officer; Exec VP, and COO | 7 | 2010–2011 | |
| RANIERI RICHARD J | Officer; Other | EVP, Human Resources; SVP, Human Resources | 20 | 2010–2013 | |
| STUMP DAVID C | Director | 7 | 2010–2014 | person page Fuzzy | |
| JOHNSON JOHN | Director; Director,Officer | Chief Executive Officer; Pres & Chief Executive Officer | 13 | 2011–2014 | |
| OSBORN JOHN E | Officer | EVP, General Counsel | 4 | 2011–2012 | |
| FENTON DENNIS M | Director | 4 | 2011–2014 | ||
| Cvijic Christine Mikail | Officer | EVP, Corp Dev, Gen Cnsl/Scrtry; EVP, Corp Dev, Gen Counsel | 9 | 2012–2014 | |
| DePinto Joseph I | Officer | EVP, Global Commercial Ops | 10 | 2012–2014 | |
| Poulton Robert S | Officer | EVP, Technical Operations | 5 | 2012–2013 | |
| Rocco Lindsay | Officer | EVP, Corporate Communications | 8 | 2012–2014 | |
| Monteith William | Officer; Other | EVP, Technical Operaations; EVP Technical Operations; EVP, Technical Operations | 29 | 2012–2015 | |
| Mayes, Gregory T. | Officer | EVP Human Resources | 2 | 2013 | |
| Sandler Andrew Seth | Officer | EVP, Chief Medical Officer | 16 | 2014–2015 | |
| Brophy Karen | Officer | VP, Human Resources | 11 | 2014–2015 | |
| Jenkinson William | Officer | Chief Marketing Officer | 4 | 2014 | |
| Pacheco Silvio | Officer | Chief Customer Officer; SVP, Sales and Marketing | 7 | 2014–2015 | |
| Crotty Robert | Officer | EVP, General Counsel; VP, Interim General Counsel | 10 | 2014–2015 | |
| Amick W Thomas | Director,Officer | Pres & Chief Executive Officer | 2 | 2014 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | DENDREON CORPORATION | WA | State business registries | name and state |
| Plan sponsor | DENDREON PHARMACEUTICALS LLC | CA | Form 5500 (employee benefit plans) | EIN (EXACT) |
| Federal award recipient | DENDREON CORPORATION | WA | Federal spending (USAspending) | name and state |
| Lobbying client | DENDREON CORP. | WA | Federal lobbying (LDA) | name and state |
| Lobbying client | DENDREON CORPORATION | WA | Federal lobbying (LDA) | name and state |
| Lobbying client | DENDREON CORPORATION | WA | Federal lobbying (LDA) | name and state |
| Patent assignee | Dendreon Corporation | WA | Patents (USPTO) | name and state |
| SEC filer | DENDREON CORP | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Dendreon Corporation | WA | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | DENDREON PHARMACEUTICALS LLC | EIN (EXACT) | ||
| Person page | David C Stump MD | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) | |
| Person page | Douglas G Watson | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) | |
| Person page | Pedro P Granadillo | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, WA first:
- PATHOGENESIS CORP WA
- CORUS PHARMA INC WA
- CytoDyn Inc. WA
- OMEROS CORP WA
- Trubion Pharmaceuticals, Inc WA
- Light Sciences Oncology Inc WA
- Cocrystal Pharma, Inc. WA
- ALDER BIOPHARMACEUTICALS INC WA
- PHASERX, INC. WA
- CHINOOK THERAPEUTICS, INC. WA
In other datasets, the same topic (Health) in WA:
- Nonprofit: ACUPUNCTURE RELIEF PROJECT (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health